Literature DB >> 3595683

Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancer.

L Castagnetta, A Traina, A Di Carlo, A M Latteri, G Carruba, R E Leake.   

Abstract

Both soluble and nuclear oestrogen receptors were measured in at least two different portions of primary breast cancer and in concurrent metastatic tissue from axillary nodes. Oestrogen receptor (ER) status of involved nodes was found highly consistent with that of primary tumours. Of the 67 patients studied, 30 had metastatic nodes which contained both soluble and nuclear ER. Of these, 27 were associated with a primary cancer which also had both soluble and nuclear ER, determined in at least two separate parts of the primary cancer. Conversely, none of the completely negative primaries gave rise to fully receptor positive metastatic tissue. Surprisingly, 17 out of 20 heterogeneous primary tumours, i.e. those containing both receptor positive and negative components, generated receptor negative metastatic nodes. Moreover, in 7 of the 8 patients with N-2 stage nodal involvement, the metastatic disease had arisen from primaries which were either completely receptor negative or with a heterogeneous ER status. It is suggested that macroscopic heterogeneity of ER status in primary breast cancer is associated with poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595683     DOI: 10.1016/0277-5379(87)90415-9

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  8 in total

Review 1.  Targeted functional imaging in breast cancer.

Authors:  Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03       Impact factor: 9.236

2.  Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy.

Authors:  L Castagnetta; G Carruba; M Calabrò; L Polito; L Blasi; M Pavone-Macaluso
Journal:  Urol Res       Date:  1991

3.  Immunoblotting for breast carcinoma in infiltrated lymph nodes.

Authors:  A A Hakim; M Durkin
Journal:  Naturwissenschaften       Date:  1988-07

4.  Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.

Authors:  S von Kleist; J Berling; J Koltzenburg; H Gropp
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate.

Authors:  L Castagnetta; G Carruba; E Fecarotta; M Lo Casto; R Cusimano; M Pavone-Macaluso
Journal:  Urol Res       Date:  1992

6.  Do multiple oestrogen receptor assays give significant additional information for the management of breast cancer?

Authors:  L Castagnetta; A Traina; A Di Carlo; G Carruba; M Lo Casto; M Mesiti; R Leake
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

7.  The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes.

Authors:  L Castagnetta; A Traina; G Carruba; E Fecarotta; G Palazzotto; R Leake
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

8.  Measurement of oestrogen receptor mRNA levels in human breast tumours.

Authors:  J A Henry; S Nicholson; J R Farndon; B R Westley; F E May
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.